A multicentral prospective cohort trial of a pharmacist-led nutritional intervention on serum potassium levels in outpatients with chronic kidney disease: The MieYaku-Chronic Kidney Disease project.

Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE

Original Publication: San Francisco, CA : Public Library of Science

Renal Insufficiency, Chronic*/diet therapy ; Renal Insufficiency, Chronic*/blood ; Renal Insufficiency, Chronic*/therapy ; Potassium*/blood ; Outpatients* ; Pharmacists* ; Glomerular Filtration Rate*; Humans ; Female ; Male ; Prospective Studies ; Aged ; Middle Aged ; Japan ; Hyperkalemia/prevention & control ; Hyperkalemia/blood ; Hyperkalemia/diet therapy ; Potassium, Dietary/administration & dosage ; Aged, 80 and over

Although dietary potassium restriction is an acceptable approach to hyperkalemia prevention, it may be insufficient for outpatients with chronic kidney disease (CKD). Most outpatients with CKD use community pharmacies owing to the free access scheme in Japan. The MieYaku-CKD project included a community pharmacist-led nutritional intervention for dietary potassium restriction, with the goal of determining its efficacy for patients' awareness of potassium restriction and serum potassium levels in outpatients with CKD. This was a five-community pharmacy multicenter prospective cohort study with an open-label, before-and-after comparison design. Eligible patients (n = 25) with an estimated glomerular filtration rate (eGFR) < 45 mL/min/1.73 m2 received nutritional guidance from community pharmacists. The primary outcome was a change in serum potassium levels at 12 weeks post-intervention. The eligible patients' knowledge, awareness, and implementation of potassium restriction were evaluated using a questionnaire. The median value of serum potassium was significantly reduced from 4.7 mEq/L before to 4.4 mEq/L after the intervention [p < 0.001, 95% confidence interval (CI): 0.156-0.500], with no changes in eGFR (p = 0.563, 95% CI: -2.427-2.555) and blood urine nitrogen/serum creatinine ratio (p = 0.904, 95% CI: -1.793-1.214). The value of serum potassium had a tendency of attenuation from 5.3 to 4.6 mEq/L (p = 0.046, 95% CI: 0.272-1.114) in the eGFR < 30 mL/min/1.73 m2 group. A questionnaire revealed that after the intervention, knowledge and attitudes regarding dietary potassium restriction were much greater than before, suggesting that the decrease in serum potassium levels may be related to this nutritional guidance. Our findings indicate that implementing a dietary potassium restriction guidance program in community pharmacies is feasible and may result in lower serum potassium levels in outpatients with CKD.
Competing Interests: The authors have declared that no competing interests exist.
(Copyright: © 2024 Asai et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.)

N Engl J Med. 2004 Aug 5;351(6):543-51. (PMID: 15295047)
Am J Kidney Dis. 2023 Sep;82(3):257-266.e1. (PMID: 37182596)
Nutrients. 2021 Dec 13;13(12):. (PMID: 34959995)
Kidney Int Suppl (2011). 2015 Jun;5(1):2-7. (PMID: 26097778)
Medicina (Kaunas). 2022 Feb 14;58(2):. (PMID: 35208608)
J Am Pharm Assoc (2003). 2022 Nov-Dec;62(6):1816-1822.e2. (PMID: 35965233)
Kidney Res Clin Pract. 2016 Jun;35(2):78-83. (PMID: 27366661)
PLoS One. 2017 Sep 6;12(9):e0184402. (PMID: 28877239)
J Am Heart Assoc. 2020 Jun 16;9(12):e015719. (PMID: 32500831)
Am Heart J. 2022 Jan;243:177-186. (PMID: 34610282)
Biosci Trends. 2018 Jan 9;11(6):632-639. (PMID: 29249774)
Int Urol Nephrol. 2022 Apr;54(4):949-957. (PMID: 34331637)
J Ren Nutr. 2023 Jul;33(4):566-574. (PMID: 36791982)
Nutrients. 2018 Feb 25;10(3):. (PMID: 29495340)
Kidney Int. 1996 Mar;49(3):800-5. (PMID: 8648923)
Eur Heart J. 2018 Jun 21;39(24):2314-2325. (PMID: 29522134)
Adv Chronic Kidney Dis. 2017 Sep;24(5):315-318. (PMID: 29031358)
BMJ. 2015 Mar 23;350:h1586. (PMID: 25801454)
J Ren Nutr. 2020 Jul;30(4):276-285. (PMID: 31734057)
BMC Nephrol. 2020 Oct 31;21(1):453. (PMID: 33129292)
BMC Public Health. 2011 Jul 21;11:582. (PMID: 21777456)
Eur J Clin Nutr. 2021 Sep;75(9):1389-1397. (PMID: 33531632)
Nihon Jinzo Gakkai Shi. 2013;55(5):585-860. (PMID: 23980478)
J Am Med Dir Assoc. 2004 Mar-Apr;5(2 Suppl):S67-71. (PMID: 14984614)
Nutrients. 2021 Sep 19;13(9):. (PMID: 34579153)
Eur J Heart Fail. 2021 Oct;23(10):1698-1707. (PMID: 34196082)
Kidney Int. 2011 Jan;79(2):218-27. (PMID: 20811332)
Arch Intern Med. 2009 Jun 22;169(12):1156-62. (PMID: 19546417)
Kidney Med. 2021 Jun 01;3(4):576-585.e1. (PMID: 34401725)

RWP5GA015D (Potassium)
0 (Potassium, Dietary)

Date Created: 20240531 Date Completed: 20240531 Latest Revision: 20240626

20240627

PMC11142692

10.1371/journal.pone.0304479

38820514